IS6690A - Trísýklísk 2-pýridon efnasambönd, nýtileg sem HIVvíxlritatálmar - Google Patents

Trísýklísk 2-pýridon efnasambönd, nýtileg sem HIVvíxlritatálmar

Info

Publication number
IS6690A
IS6690A IS6690A IS6690A IS6690A IS 6690 A IS6690 A IS 6690A IS 6690 A IS6690 A IS 6690A IS 6690 A IS6690 A IS 6690A IS 6690 A IS6690 A IS 6690A
Authority
IS
Iceland
Prior art keywords
tricyclic
crossover
hiv
inhibitors
useful
Prior art date
Application number
IS6690A
Other languages
English (en)
Inventor
D. Rodgers James
Wang Haisheng
Patel Mona
Arvanitis Argyrios
J. Cocussa Anthony
Original Assignee
Bristol-Myers Squibb Pharma Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Pharma Company filed Critical Bristol-Myers Squibb Pharma Company
Publication of IS6690A publication Critical patent/IS6690A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS6690A 2000-07-20 2003-01-17 Trísýklísk 2-pýridon efnasambönd, nýtileg sem HIVvíxlritatálmar IS6690A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21953200P 2000-07-20 2000-07-20
US28485601P 2001-04-19 2001-04-19
PCT/US2001/022827 WO2002008226A2 (en) 2000-07-20 2001-07-20 Tricyclic 2-pyridone compounds useful as hiv reverse transcriptase inhibitors

Publications (1)

Publication Number Publication Date
IS6690A true IS6690A (is) 2003-01-17

Family

ID=26913986

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6690A IS6690A (is) 2000-07-20 2003-01-17 Trísýklísk 2-pýridon efnasambönd, nýtileg sem HIVvíxlritatálmar

Country Status (23)

Country Link
US (1) US6596729B2 (is)
EP (1) EP1303515A2 (is)
JP (1) JP2004532793A (is)
KR (1) KR20030065454A (is)
CN (1) CN1464878A (is)
AR (1) AR031861A1 (is)
AU (1) AU2001280641A1 (is)
BG (1) BG107439A (is)
BR (1) BR0112606A (is)
CA (1) CA2418194A1 (is)
EE (1) EE200300027A (is)
HU (1) HUP0302862A2 (is)
IL (1) IL153683A0 (is)
IS (1) IS6690A (is)
LT (1) LT2003003A (is)
LV (1) LV13024B (is)
MX (1) MXPA03000434A (is)
NO (1) NO20030248L (is)
PL (1) PL365958A1 (is)
SI (1) SI21139A (is)
SK (1) SK392003A3 (is)
WO (1) WO2002008226A2 (is)
YU (1) YU3203A (is)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101629B2 (en) 2001-08-13 2012-01-24 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
US7638522B2 (en) 2001-08-13 2009-12-29 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
TW200306192A (en) 2002-01-18 2003-11-16 Bristol Myers Squibb Co Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors
AR039540A1 (es) 2002-05-13 2005-02-23 Tibotec Pharm Ltd Compuestos microbicidas con contenido de pirimidina o triazina
BR0313545B1 (pt) * 2002-08-09 2021-07-27 Janssen Pharmaceutica Nv processos para a preparação de 4-[[4-[[4-(2-cianoetenil)-2,6-dimetilfenil]amino]-2-pirimidinil]amino]benzonitrila
CA2513527C (en) 2003-02-07 2012-08-14 Janssen Pharmaceutica N.V. Pyrimidine derivatives for the prevention of hiv infection
AP2006003791A0 (en) 2004-05-17 2006-10-31 Tibotec Pharm Ltd 1-Heterocyclyl-1,5-dihydro-pyridoÄ3,2-BÜindol-2-ones

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700673A (en) * 1971-02-12 1972-10-24 Morton Norwich Products Inc 3-4-dihydrobenzo(b) (1,7)naphthyridin-1(2h)-ones
GB9023289D0 (en) 1990-10-25 1990-12-05 Ici Plc Herbicides
IL102764A0 (en) 1991-08-16 1993-01-31 Merck & Co Inc Quinazoline derivatives,and pharmaceutical compositions containing them
AU2436792A (en) * 1991-08-16 1993-03-16 Merck & Co., Inc. Quinazoline derivatives as inhibitors of hiv reverse transcriptase
DE4320347A1 (de) 1993-06-19 1994-12-22 Boehringer Mannheim Gmbh Quinazolin-Derivate und diese enthaltende Arzneimittel
AU1046895A (en) 1993-11-05 1995-05-23 Merck & Co., Inc. New quinazolines as inhibitors of hiv reverse transcriptase
DE4344452A1 (de) 1993-12-24 1995-06-29 Hoechst Ag Aza-4-iminochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung
ID18046A (id) 1996-08-20 1998-02-19 Takeda Chemical Industries Ltd Senyawa siklik campuran, pembuatan dan penngunaannya.
WO1998014436A1 (en) 1996-10-02 1998-04-09 Dupont Pharmaceuticals Company 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same
HRP980143A2 (en) 1997-04-09 1999-02-28 Soo Sung Ko 4,4-disubstituted-3,4-dihydro-2 (1h)-quinazolinones useful as hiv reverse transcriptase inhibitors
US6593337B1 (en) 1999-10-19 2003-07-15 Bristol-Myers Squibb Pharma Company Tricyclic compounds useful as HIV reverse transcriptase inhibitors

Also Published As

Publication number Publication date
YU3203A (sh) 2006-01-16
AR031861A1 (es) 2003-10-08
SK392003A3 (en) 2003-10-07
IL153683A0 (en) 2003-07-06
US6596729B2 (en) 2003-07-22
KR20030065454A (ko) 2003-08-06
NO20030248D0 (no) 2003-01-17
EP1303515A2 (en) 2003-04-23
WO2002008226A3 (en) 2002-06-20
BR0112606A (pt) 2004-06-29
EE200300027A (et) 2004-10-15
CN1464878A (zh) 2003-12-31
SI21139A (sl) 2003-08-31
CA2418194A1 (en) 2002-01-31
AU2001280641A1 (en) 2002-02-05
US20020107261A1 (en) 2002-08-08
WO2002008226A2 (en) 2002-01-31
NO20030248L (no) 2003-03-17
LT2003003A (en) 2003-11-25
MXPA03000434A (es) 2003-06-24
HUP0302862A2 (hu) 2003-12-29
JP2004532793A (ja) 2004-10-28
BG107439A (bg) 2003-09-30
LV13024B (en) 2003-10-20
PL365958A1 (en) 2005-01-24

Similar Documents

Publication Publication Date Title
IS6846A (is) Nikotínamíð bíarýlafleiður, nytsamlegar sem hindrar PDE4 samsætuensíma
IS6847A (is) Eterafleiður, nytsamlegar sem hindrar PDE4 samsætuensíma
DE10195908T1 (de) Blockcopolymer
DK1333876T3 (da) Detekterbar, svær nål
EE05223B1 (et) Triasoloprimidiini hendid, meetod nende valmistamiseks ning nende kasutamine
NO20026195D0 (no) Substituerte-triazolopyrimidiner som anticancer midler
IS6858A (is) Trísólpýridín sem bólgueyðandi efni
ITTO20011143A0 (it) ,,portafusibili modulare,,.
NO20025525D0 (no) Substituerte pyrrolpyridinonderivater, brukbare som fosfordiesterase-inhibitorer
IL149219A0 (en) Tricyclic compounds useful as hiv reverse transcriptase inhibitors
AR027983A1 (es) Novedosos compuestos
NO20024893D0 (no) Fremgangsmåter for ansamitocin-produksjon
ITMI20001308A0 (it) Apparecchio di taglio.
DE60142478D1 (de) Spannwerkzeughalter
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
IS6690A (is) Trísýklísk 2-pýridon efnasambönd, nýtileg sem HIVvíxlritatálmar
AR028248A1 (es) Nuevos compuestos 2,3,4,5-tetrahidro-1h-(1,4) diazepino (1,7-a) indol
IS7341A (is) Trísýklísk 2-pýrimídón efnasambönd, gagnleg sem HIV-víxlritatálmar
MXPA03009482A (es) Compuestos triciclicos utiles como inhibidores de la transcriptasa inversa del virus de inmunodeficiencia humana (vih).
IS6657A (is) Ný efnasambönd
AR028220A1 (es) Novedosos compuestos
ID29978A (id) Alat penggerak untuk alat pensaklaran, terutama untuk saklar pembumian dari lengkapan penghubung tegangan menengah
NO20024502D0 (no) 4-okso-1,4-dihydro-3-cinnolinkarboksamider som antivirale midler
AR028399A1 (es) Nuevos compuestos
CH695521A5 (de) Strombegrenzendes Bauelement.